Results 111 to 120 of about 85,538 (123)

SY13-3 The role of deferred cytoreductive nephrectomy in the era of immune checkpoint inhibitor

Annals of Oncology, 2023
openaire   +1 more source

PD24-04 OUTCOMES OF DEFERRED CYTOREDUCTIVE NEPHRECTOMY FOLLOWING PRIMARY IMMUNOTHERAPY IN ADVANCED RENAL CELL CARCINOMA: A MULTICENTER ANALYSIS

Journal of Urology, 2023
Kevin Hakimi, Ava Saidian, Justine Panian, Pedro Barata, Stephanie Berg, Steven Chang, Renee Saliby, Hannah Dzimitrowicz, Hamid Emamekhoo, Evan Gross, Deepak Kilari, Elaine Lam, Mimi Nguyen, Margaret Meagher, Grant Rauterkus, Vincent D'Andrea, Kendrick Yim, Sarah Psutka, Bicky Thapa, Nicole Weise, Tian Zhang, Rana McKay, Ithaar Derweesh   +22 more
openaire   +1 more source

Impact of Cytoreductive Nephrectomy in Patients With Primary Metastatic Renal Cell Carcinoma Receiving Systemic Tyrosine Kinase Inhibitor Therapy: A Multicenter Retrospective Study

International Journal of Urology, 2021
Renpei Kato, Yoshihide Kawasaki, Hiroyuki Nishiyama   +2 more
exaly  

Deferred Cytoreductive Nephrectomy in Synchronous Metastatic Renal Cell Carcinoma: The NORDIC-SUN-Trial

Case Medical Research, 2019
openaire   +1 more source

MP14-16 UPFRONT CYTOREDUCTIVE NEPHRECTOMY WITH DEFERRED SYSTEMIC THERAPY FOR METASTATIC RENAL CELL CARCINOMA

Journal of Urology
Bimal Bhindi, Ranjeeta Mallick, Camilla Tajzler, Rahul Bansal, Naveen Basappa, Georg Bjarnason, Lucas Dean, Antonio Finelli, Aly-Khan Lalani, Luke Lavallee, Miles Mannas, Jay Nayak, Frederic Pouliot, Nicholas Power, Ricardo Rendon, Simon Tanguay, Lori Wood, Rodney Breau   +17 more
openaire   +1 more source

PD24-02 IMPACT OF SYSTEMIC THERAPY (ST) ON DEFERRED CYTOREDUCTIVE NEPHRECTOMY (CN) PERIOPERATIVE OUTCOMES: A NATIONAL SURGICAL QUALITY IMPROVEMENT PROGRAM (NSQIP) ANALYSIS

Journal of Urology, 2023
Shawn Dason, Tyler Sheetz, Shagnik Ray, Danielle Zimmerman, Ming Yin, Edmund Folefac, Amir Mortazavi, Michael Gong, Ahmad Shabsigh, Tasha Posid, Eric Singer   +10 more
openaire   +1 more source

Deferred Cytoreductive Nephrectomy Following Presurgical Vascular Endothelial Growth Factor Receptor–Targeted Therapy in Patients With Primary Metastatic Clear Cell Renal Cell Carcinoma: A Pooled Analysis of Prospective Trial Data

European Urology Oncology, 2020
John B A G Haanen, Thomas Powles, Tobias Klatte   +2 more
exaly  

Cytoreductive Surgery and Adjuvant Immunotherapy: A New Management Paradigm for Metastatic Melanoma

Ca-A Cancer Journal for Clinicians, 1999
Richard Essner, David W. Ollila, Rishab K Gupta   +2 more
exaly  

Outcome of Patients With Metastatic Renal Cell Carcinoma Treated With Targeted Therapy Without Cytoreductive Nephrectomy

Annals of Oncology, 2011
Nizar Tannir, Eric Jonasch, P G Corn
exaly  

IP40-27 LONG-TERM TREATMENT-FREE CANCER CONTROL ACHIEVED THROUGH DEFERRED CYTOREDUCTIVE NEPHRECTOMY IN SELECTED PATIENTS WITH MRCC

Journal of Urology
Ryuma Tanaka, Masanao Shinohara, Yohei Kawashima, Yuya Sekine, Shintaro Narita, Shin Kobayashi, Noriyuki Abe, Hirotake Kodama, Naoki Fujita, Teppei Okamoto, Hayato Yamamoto, Kazuyuki Numakura, Satoshi Sato, Tomonori Habuchi, Chikara Ohyama, Shingo Hatakeyama   +15 more
openaire   +1 more source